Literature DB >> 16527835

A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

C G P Roberts1, L K Hummers, W J Ravich, F M Wigley, G M Hutchins.   

Abstract

BACKGROUND: Atrophy of the smooth muscle layers of the muscularis propria characterises oesophageal involvement in systemic sclerosis (scleroderma). The aetiology of this atrophy and of the resultant oesophageal dysfunction is unknown.
OBJECTIVES: To examine oesophageal tissue for evidence of fibrosis, vascular disease, inflammatory reactions and neural abnormalities to determine the possible causes of this disease process.
METHODS: A case-control survey was conducted using oesophageal tissue from 74 scleroderma cases and 74 age, race and sex-matched controls from our autopsy files. Histological evidence of oesophageal muscle atrophy was correlated with the degree of vascular changes, inflammatory infiltration, fibrosis, abnormalities of the myenteric plexus and reduction of interstitial cells of Cajal (ICC) using a predesigned semiquantitative descriptive method.
RESULTS: Smooth-muscle atrophy was found in 94% of scleroderma cases, and in 5% of controls (p<0.001). Atrophy was evident in the circular smooth muscle in 93% of cases, and in the longitudinal smooth muscle in 66% of cases. Intimal proliferation of arterioles was found in 38% of cases and in 5% of controls (p<0.001), but was not associated with smooth-muscle atrophy (p = 0.29). Despite these vascular changes, there was no evidence of compromised perfusion, such as findings suggestive of acute ischaemic necroses. Minimal cellular infiltrates were seen in the myenteric plexus in 82% of cases and in 92% of controls (p = 0.091). ICC were found in fewer numbers in areas of atrophic smooth muscle compared with adjacent normal smooth muscle in selected scleroderma cases.
CONCLUSION: The pathological findings of oesophageal lesions in scleroderma seem inconsistent with either an ischaemic or an inflammatory process. The loss of circular and longitudinal smooth muscle in the distal scleroderma oesophagus may represent loss of normal neural function followed by secondary tissue atrophy, or may be a primary smooth muscle lesion.

Entities:  

Mesh:

Year:  2006        PMID: 16527835      PMCID: PMC1856462          DOI: 10.1136/gut.2005.086074

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  SCLERODERMA OF THE ESOPHAGUS. A CORRELATION OF HISTOLOGIC AND PHYSIOLOGIC FINDINGS.

Authors:  W L TREACY; A H BAGGENSTOSS; C H SLOCUMB; C F CODE
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

2.  Esophageal lesions in diffuse scleroderma.

Authors:  J R LINDSAY
Journal:  Laryngoscope       Date:  1949-02       Impact factor: 3.325

3.  Generalized progressive scleroderma; report of an instance of esophagoscopic perforation of the esophagus with description of the roentgenological and necropsy findings.

Authors:  G S SCHWARZ; O K SKINSNES
Journal:  Am J Roentgenol Radium Ther       Date:  1949-09

4.  Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis.

Authors:  M P Greydanus; M Camilleri
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

5.  c-Kit immunoreactive interstitial cells in the human gastrointestinal tract.

Authors:  S Torihashi; M Horisawa; Y Watanabe
Journal:  J Auton Nerv Syst       Date:  1999-01-15

6.  Myenteric neuronal antibodies in scleroderma: passive transfer evokes alterations in intestinal myoelectric activity in a rat model.

Authors:  E Y Eaker; J G Kuldau; G N Verne; S O Ross; J E Sallustio
Journal:  J Lab Clin Med       Date:  1999-06

7.  Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases.

Authors:  A Malandrini; E Selvi; M Villanova; G Berti; L Sabadini; C Salvadori; S Gambelli; R De Stefano; R Vernillo; R Marcolongo; G Guazzi
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

Review 9.  Gastrointestinal motility disorders in scleroderma.

Authors:  R W Sjogren
Journal:  Arthritis Rheum       Date:  1994-09

10.  Sequential dermal microvascular and perivascular changes in the development of scleroderma.

Authors:  R J Prescott; A J Freemont; C J Jones; J Hoyland; P Fielding
Journal:  J Pathol       Date:  1992-03       Impact factor: 7.996

View more
  29 in total

Review 1.  My approach to the treatment of scleroderma.

Authors:  Ami A Shah; Fredrick M Wigley
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

2.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

Review 3.  Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.

Authors:  Genevieve Gyger; Murray Baron
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 4.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

Review 5.  Advances in the evaluation and management of esophageal disease of systemic sclerosis.

Authors:  Dustin A Carlson; Monique Hinchcliff; John E Pandolfino
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

6.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

7.  Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium.

Authors:  Elizabeth R Volkmann; Yu-Ling Chang; Nashla Barroso; Daniel E Furst; Philip J Clements; Alan H Gorn; Bennett E Roth; Jeffrey L Conklin; Terri Getzug; James Borneman; Dermot P B McGovern; Maomeng Tong; Jonathan P Jacobs; Jonathan Braun
Journal:  Arthritis Rheumatol       Date:  2016-06       Impact factor: 10.995

8.  Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis.

Authors:  Dustin A Carlson; Michael D Crowell; Jessica N Kimmel; Amit Patel; C Prakash Gyawali; Monique Hinchcliff; W Leroy Griffing; John E Pandolfino; Marcelo F Vela
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-05       Impact factor: 11.382

Review 9.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 10.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.